Skip to content

Ayurvedic management of female infertility

Efficacy of Lashunadi Taila Matrabasti along with Shatapushpa Choorna orally in the management of Vandhyatva ( Female infertility) w.s.r to anovulatory factor in Sthoulya: An open labeled single arm clinical

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/03/040864
Enrollment
20
Registered
2022-03-07
Start date
Unknown
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N970- Female infertility associated withanovulation

Interventions

None listed

Sponsors

Director ITRA Jamnagar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Female Patients of reproductive age >= 20 and Patients having overweight (BMI 25-29 Kg/M2 ) or obese (BMI >30 Kg/M2) Patients who have completed active married life of minimum1-year duration and suffering from Infertility with 2 or more consecutive anovulatory cycles. Both Primary and secondary infertile patients having anovulatory cycle or with immature ovarian follicle. Patient eligible& willing for Basti Patients willing to participate in trial

Exclusion criteria

Exclusion criteria: Female Patients having age 40years. Patient with infectious diseases of reproductive tract like tuberculosis, sexually transmitted diseases Organic lesions of reproductive tract like tuberculosis, carcinoma and congenital deformities. Patients with history of cardiac diseases, Uncontrolled Diabetes (above 200 mg/dl- RBS) & Hypertension (Systolic BP above 160 & Diastolic above 100mmhg), TB, etc. Patient with Hepatitis C, Hepatitis B Patient not eligible for Basti Pitta dominant Prakruti patients

Design outcomes

Primary

MeasureTime frame
It is expected that the trial drugs will induce the ovulation.Timepoint: 3 months

Secondary

MeasureTime frame
Trail drugs will cure menstrual abnormalities associated with anovulation like irregular, scanty menstruation, dysmenorrhoea It is expected that drugs will help to reduce BMI of patient. Timepoint: 3 months

Countries

India

Contacts

Public ContactProf Shilpa B Donga

ITRA Jamnagar

drshilpadonga@yahoo.com9825646796

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026